Lupin launches generic Ancobon capsules in US

Lupin launches generic Ancobon capsules in US

Lupin logo

 

Lupin has launched Flucytosine capsules and received USFDA approval. The Flucytosine capsule is sused to treat serious infections, in the American market.

The company has launched its generic product in the strengths of 250 mg and 500 mg.

Flucytosine capsules have annual sales of around USD 48 million in the US, as per the latest IMS sales data.